NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Sutro Biopharma Inc (NASDAQ: STRO)

 
STRO Technical Analysis
5
As on 9th Jun 2023 STRO STOCK Price closed @ 5.33 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 7.34 & Strong Sell for SHORT-TERM with Stoploss of 11.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

STROSTOCK Price

Open 5.12 Change Price %
High 5.37 1 Day 0.21 4.10
Low 5.07 1 Week 0.43 8.78
Close 5.33 1 Month 0.72 15.62
Volume 373783 1 Year -10.48 -66.29
52 Week High 15.81 | 52 Week Low 3.41
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
STRO
Daily Charts
STRO
Intraday Charts
Whats New @
Bazaartrend
STRO
Free Analysis
 
STRO Important Levels Intraday
RESISTANCE5.91
RESISTANCE5.72
RESISTANCE5.61
RESISTANCE5.49
SUPPORT5.17
SUPPORT5.05
SUPPORT4.94
SUPPORT4.75
 
STRO Forecast May 2024
4th UP Forecast18.22
3rd UP Forecast14.09
2nd UP Forecast11.53
1st UP Forecast8.98
1st DOWN Forecast1.68
2nd DOWN Forecast-0.87
3rd DOWN Forecast-3.43
4th DOWN Forecast-7.56
 
STRO Weekly Forecast
4th UP Forecast9.34
3rd UP Forecast8.05
2nd UP Forecast7.26
1st UP Forecast6.46
1st DOWN Forecast4.20
2nd DOWN Forecast3.40
3rd DOWN Forecast2.61
4th DOWN Forecast1.32
 
STRO Forecast2024
4th UP Forecast29.96
3rd UP Forecast22.06
2nd UP Forecast17.18
1st UP Forecast12.3
1st DOWN Forecast-1.64
2nd DOWN Forecast-6.52
3rd DOWN Forecast-11.4
4th DOWN Forecast-19.3
 
 
STRO Other Details
Segment EQ
Market Capital 946019648.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
STRO Address
STRO
 
STRO Latest News
 
Your Comments and Response on Sutro Biopharma Inc
 
STRO Business Profile
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF. The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials. It has collaboration and license agreements with Merck Collaboration to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; and Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused primarily on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California. Address: 310 Utah Avenue, South San Francisco, CA, United States, 94080
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service